Biostimulator in the temples: indication and precautions

· 7 min read

Editorial illustration about a biostimulator in the temples

Hollowing of the temples is one of the earliest signs of facial volume loss and changes how the upper third reads: the face looks more "skeletal," the tail of the eyebrow loses support and the lateral contour is broken. The biostimulator appears as an option because it restores volume gradually and lastingly. However, the same area is among the highest vascular risk areas of the face, and that weighs more with a product that cannot be undone.

This guide covers indication, risk anatomy, product choice and expectations, at review level. It does not include plans, volumes, dilutions or technique, which are decisions for the qualified professional, according to the product's instructions for use and the rules of their professional council.

What is in the temporal region?

The temporal fossa is bounded by the superior temporal line, the lateral orbital rim, the zygomatic arch and the region above the ear. From the surface to the depth, the layers include:

Layer What it contains Point of concern
Skin and subcutaneous tissue Thin skin in the anterior portion Visible irregularity with superficial product
Temporoparietal fascia Continuation of the SMAS Contains the superficial temporal artery and its branches, and the temporal branch of the facial nerve
Deep temporal fascia Superficial and deep layers Between them, the temporal fat pad and the middle temporal vein
Temporalis muscle Muscle of mastication The middle temporal artery and the deep temporal arteries lie in deep planes
Bone Floor of the fossa Depth reference

There is no "vessel-free" plane in the region. The detailed anatomy, with layers and boundaries, is in the temples area page.

Why do the temples hollow out?

  • Aging: loss of superficial and deep fat, reduced muscle volume and bone remodeling.
  • Significant weight loss, including with weight-loss medications. See facial volume loss after weight loss.
  • Intense physical activity and low body fat percentage.
  • Facial lipodystrophy, in some health conditions and treatments.
  • Constitution: some people have concave temples from a young age.

Always ask about the cause, because it changes the prognosis. With weight loss still ongoing, for example, treating now may require new planning later.

When does a biostimulator make sense in the temples?

Situation Is a biostimulator likely to be an option? Comment
Mild to moderate hollowing, diffuse volume loss Yes, if the area is covered by the instructions for use Gradual result, over sessions
Patient who wants an immediate result Rarely Hyaluronic acid delivers volume the same day
Patient who values being able to reverse No Hyaluronic acid is degradable with hyaluronidase
Marked hollowing Partly May require a combination and several stages
Very thin skin in the anterior portion Caution Nodules are more visible
Ongoing weight loss Postpone Stabilize weight before planning

Planning for the whole face, when the hollowing is part of global volume loss, is in full face biostimulator.

Which biostimulator?

The most cited classes are poly-L-lactic acid, calcium hydroxylapatite and polycaprolactone. Differences in immediate effect, pace and management are in calcium hydroxylapatite vs. poly-L-lactic acid and polycaprolactone vs. poly-L-lactic acid.

Biostimulator or hyaluronic acid in the temples?

Biostimulator Hyaluronic acid
Effect Gradual, through collagen Immediate, through gel volume
Sessions Usually more than one Can be one, with a follow-up
Reversal by enzyme No Yes, with hyaluronidase
Management of vascular complication No specific enzyme Hyaluronidase as the central resource
Duration Long, varies with product and patient Varies with product and area

Hyaluronic acid filler is covered in temple filler. The two can be combined at different moments of the plan, at the professional's discretion. When the plan uses hyaluronic acid, hyaluronidase must be available.

What to expect over the months?

Moment What usually happens
First days Swelling, tenderness when chewing, possible bruises; with some products, an initial effect from the carrier
First weeks The initial effect fades; the patient may think it went back to how it was
A few months Gradual volume replacement, following collagen production
After the cycle Assessment with photos and a decision about maintenance

Timeframes vary with the product, the sessions and the patient. The patient's questions about this are in when the biostimulator result appears.

What other risks should be considered?

  • Nodules and irregularities, especially in the anterior portion, where the skin is thinner. See nodules after a biostimulator.
  • Pain when chewing and temporary tenderness, because of the proximity of the temporalis muscle.
  • Hematoma, because of the region's rich venous supply.
  • Asymmetry between sides.
  • Altered eyebrow movement, rare, because of the proximity of the temporal branch of the facial nerve.
  • Vascular occlusion, rare and serious.

The overall picture of complications for the class is in complications with biostimulators.

What are the most common mistakes?

  • Assessing only from the front. Temporal hollowing shows in three-quarter view and in profile, and missing those photos prevents comparison at the follow-up.
  • Treating without knowing the cause. With ongoing weight loss, the restored volume can end up disproportionate once weight stabilizes.
  • Trying to solve it in one session. The biostimulator works through gradual stimulation; too much product per session raises the risk of nodules.
  • Choosing a biostimulator for someone who wants reversibility. The patient anxious about "what if I don't like it?" is usually calmer with hyaluronic acid.
  • Forgetting the eyebrow. The temple and the tail of the eyebrow work together; it is worth assessing the eyebrow in the same exam.
  • Not aligning on the initial effect. With products that give volume on the day, the reduction in the first weeks looks like a "loss" if the patient was not warned.

How to explain it to the patient?

Use an informed consent that mentions the vascular risk of the area, nodules and the absence of enzymatic reversal. There is an informed consent template for biostimulator.

And in Harmy?

Checklist before a biostimulator in the temples

  1. Cause of the hollowing identified; stable weight.
  2. Temporal region covered by the instructions for use of the registered product.
  3. Vascular anatomy and complication protocol reviewed.
  4. Patient informed about the gradual effect, vascular risk and the absence of enzymatic reversal.
  5. Photos from the front, three-quarter view and profile, with hair pinned back.
  6. Product, lot, expiration date and volume per side in the patient record.
  7. Follow-ups and interval between sessions planned.

Frequently asked questions

Is a biostimulator in the temples safe?

The temples are a high vascular risk area for any injectable, and a biostimulator cannot be broken down by an enzyme in case of a complication. The indication requires detailed anatomical knowledge, a product whose instructions for use cover the area and a complication protocol.

Biostimulator or hyaluronic acid in the temples?

Hyaluronic acid gives immediate volume and can be broken down with hyaluronidase. The biostimulator restores volume gradually, through collagen stimulation, with no enzymatic reversal. The choice depends on the degree of hollowing, the skin, expectations and the product's approved indication.

How long does it take to see the result of a biostimulator in the temples?

The result usually appears gradually, over months, as collagen forms. With some products there is an initial effect from the carrier, which fades in the first weeks.

Why do the temples hollow out?

With aging there is loss of fat and muscle volume and bone remodeling in the temporal region. Significant weight loss, intense physical activity and some health conditions also accentuate the hollowing.

Harmy images are illustrative simulations generated by AI from the patient's photo to support the conversation between practitioner and patient. They are not a promise of results. Indication, technique, product and volume are solely the decision of the licensed practitioner. This content is for information only and does not replace a clinical assessment.

Terms mentioned

Related reading